CLDI · Categories · Form 4

CLDI - SEC Form 4 insider transactions

Calidi Biotherapeutics Inc. (CLDI) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CLDI

• 174d
  Director Camaisa Allan sold $1,237 worth of shares (850 units at $1.46) (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 276d
  SEC Form 4 filed by Chief Executive Officer Poma Eric E

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 276d
  SEC Form 4 filed by Chief Scientific Officer Fernandez Santidrian Antonio

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 276d
  SEC Form 4 filed by Chief Financial Officer Jackson Andrew C.

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 328d
  SEC Form 4 filed by Director Leftwich Scott

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 328d
  SEC Form 4 filed by Director Peoples George

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 328d
  SEC Form 4 filed by Director Schoeneck James A

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 328d
  SEC Form 4 filed by Director Stewart Alan R.

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 409d
  SEC Form 4 filed by Chief Executive Officer Poma Eric E

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 521d
  Director Stewart Alan R. was granted 12,771 shares, increasing direct ownership by 79% to 28,976 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 521d
  Director Leftwich Scott was granted 11,684 shares, increasing direct ownership by 21% to 67,774 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 537d
  CEO and Chairman of the Board Camaisa Allan sold $16,200 worth of shares (10,000 units at $1.62), decreasing direct ownership by 13% to 66,712 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 601d
  SEC Form 4 filed by Director Stewart Alan R.

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 601d
  SEC Form 4 filed by Director Leftwich Scott

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 601d
  SEC Form 4 filed by Director Peoples George

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 601d
  SEC Form 4 filed by Director Schoeneck James A

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 616d
  CEO and Chairman of the Board Camaisa Allan was granted 70,155 shares (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 697d
  SEC Form 4 filed by Director Peoples George

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 706d
  Director Leftwich Scott was granted 67,187 shares, increasing direct ownership by 14% to 560,873 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 706d
  Director Schoeneck James A was granted 79,687 shares, increasing direct ownership by 8% to 1,071,781 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 706d
  Director Stewart Alan R. was granted 73,437 shares, increasing direct ownership by 91% to 154,087 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 706d
  Director Leftwich Scott was granted 23,783 shares, increasing direct ownership by 5% to 493,686 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 706d
  Director Schoeneck James A was granted 28,207 shares, increasing direct ownership by 3% to 992,094 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 706d
  Director Stewart Alan R. was granted 25,995 shares, increasing direct ownership by 48% to 80,650 units (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 718d
  SEC Form 4 filed by Chief Financial Officer Jackson Andrew C.

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 718d
  SEC Form 4 filed by CEO and Chairman of the Board Camaisa Allan

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 718d
  SEC Form 4 filed by Chief Admin. and Legal Officer Campbell Wendy Pizarro

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 718d
  SEC Form 4 filed by Interim Chief Medical Officer Minev Boris Radoslavov

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 733d
  Schoeneck James A exercised 548,000 shares at a strike of $0.20 (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)
• 777d
  Schoeneck James A was granted 375,000 shares (SEC Form 4)

  4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)

Other CLDI categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends